DULYZIFT
Live / Applied — New application — not yet assigned to an examiner (as of 31 Oct 2026)
What this means for you
Not registered yet, but its 31 Oct 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 50193192
- Mark type
- Word mark
- Filed
- 31 Oct 2026
- Attorney of record
- Eric R. Moran
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals; pharmaceutical preparations; pharmaceutical products; biologics; biosimilars; dulaglutide biosimilars; pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for for glycemic control; pharmaceutical preparations for controlling blood sugar; biosimilars for glycemic control; pharmaceutical preparations, namely, GLP-1 receptor agonists for glycemic control; pharmaceutical preparations, namely, injectable dulaglutide biosimilars; pharmaceutical preparations, namely, injectable biosimilars for the treatment of diabetes; pharmaceutical preparations, namely, injectable biosimilars for glycemic control; pharmaceutical preparations, namely, injectable biosimilars for controlling blood sugar; pharmaceutical preparations, namely, injectable GLP-1 receptor agonists for glycemic control; pharmaceutical preparations, namely, injectable GLP-1 receptor agonists for controlling blood sugar; injectors sold filled with dulaglutide biosimilars; injectors sold filled with pharmaceutical preparations for the treatment of diabetes; injectors sold filled with pharmaceutical preparations for glycemic control; injectors sold filled with pharmaceutical preparations for controlling blood sugar; injectors sold filled with biosimilars for glycemic control; injectors sold filled with GLP-1 receptor agonists for glycemic control; injectors sold filled with GLP-1 receptor agonists for controlling blood sugar
- Class 042 — Scientific and technological services: Providing information in the field of scientific and medical research related to pharmaceuticals; providing information in the field of scientific and medical research related to diabetes and diabetes treatments; research and development of pharmaceuticals; research and development of pharmaceuticals in the field of diabetes and diabetes treatments
- Class 044 — Medical, beauty and agricultural services: Providing medical information; providing health information; providing medical information in the field of diabetes and diabetes treatments; providing health information in the field of diabetes and diabetes treatments; medical and pharmaceutical consultation; pharmaceutical advice; providing information to patients in the field of administering medications; individual medical counseling services provided to patients; providing personal support services for families of patients with life threatening disorders, namely, health counseling services
Owner
- Emerge Bioscience Pte. Ltd., Singapore, SG
Prosecution history
- 31 Oct 2026 — APPLICATION FILING RECEIPT MAILED
- 31 Oct 2026 — NEW APPLICATION ENTERED